Vitamin E δ-tocotrienol levels in tumor and pancreatic tissue of mice after oral administration

Pharmacology

Volumn 83, Issue 3, 2009, Pages 157-163

  Husain, Kazim ^a   Francois, Rony A ^a   Hutchinson, Sean Z ^a   Neuger, Anthony M ^a   Lush, Richard ^a   Coppola, Domenico ^a   Sebti, Said ^a   Malafa, Mokenge P ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Tocotrienol; Tocotrienol, mice; Pancreatic cancer; Pharmacokinetics; Tissue distribution

Indexed keywords

DELTA TOCOTRIENOL; PALM OIL; TOCOPHEROL DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DRUG STRUCTURE; DRUG TISSUE LEVEL; DRUG TUMOR LEVEL; FEMALE; LIVER CLEARANCE; MAXIMUM PLASMA CONCENTRATION; MOUSE; NONHUMAN; PANCREAS CANCER; PLASMA HALF LIFE; PRIORITY JOURNAL; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADMINISTRATION, ORAL; ANIMALS; CELL LINE, TUMOR; FEMALE; HALF-LIFE; LIVER; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PANCREAS; PANCREATIC NEOPLASMS; TISSUE DISTRIBUTION; TRANSPLANTATION, HETEROLOGOUS; VITAMIN E;

EID: 58149361841     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000190792     Document Type: Article

References (37)

1. Yoshida Y, Niki E, Noguchi N: Comparative study on the action of tocopherols and tocotrienols: chemical and physical effects. Chem Phys Lipids 2003;123:63-75.
2. Schaffer S, Muller WE, Eckert G: Tocotrienols: constitutional effects in aging and disease. J Nutr 2005;135:151-154.
3. Sen CK, Khanna S, Roy S: Tocotrienols: vitamin E beyond tocopherols. Life Sci 2006;78:2088-2098.
4. Nesaretnam K, Yew WW, Wahid MB: Tocotrienols and cancer: beyond antioxidant activity. Eur J Lipid Sci Technol 2007;109:445-452.
5. Khanna S, Roy S, Park HA, Sen CK: Regulation of c-Src activity in glutamate-induced neurodegeneration. J Biol Chem 2007;282:23482-23490.
6. Naito Y, Shimozawa M, Kuroda M, Nakabe N, Manabe H, Katada K, Kokura S, Ichikawa H, Yoshida N, Noguchi N: Tocotrienols reduce 25-hydroxycholesterol- induced monocyte-endothelial cell interaction by inhibiting the surface expression of adhesion molecules. Atherosclerosis 2005;180:19-25.
7. Qureshi AA, Qureshi N, Wright JJ, Shen Z, Kramer G, Gapor A, Chong YH, DeWitt G, Ong A, Peterson DM, et al: Lowering of serum cholesterol in hypercholesterolemic humans by tocotrienols (palmvitee). Am J Clin Nutr 1991;53:1021S-1026S.
8. Qureshi AA, Burger WC, Peterson DM, Elson CE: The structure of an inhibitor of cholesterol biosynthesis isolated from barley. J Biol Chem 1986;261:10544-10550.
9. Khanna S, Roy S, Slivka A, Craft TK, Chaki S, Rink C, Notestine MA, DeVries AC, Parinandi NL, Sen CK: Neuroprotective properties of the natural vitamin E α-tocotrienol. Stroke 2005;36:2258-2264.
10. Osakada F, Hashino A, Kume E, Katsuki H, Kaneko S, Akaike A: α-Tocotrienol provides the most potent neuroprotection among vitamin E analogs on cultured striatal neurons. Neuropharmacology 2004;47:904-915.
11. Conte C, Floridi A, Aisa C, Piroddi M, Floridi A, Galli F: γ-Tocotrienol metabolism and antiproliferative effect in prostate cancer cells. Ann NY Acad Sci 2004;1031:391-394.
12. Kumar KS, Raghavan M, Heiber K, Ege C, Mog S, Parra N, Hildabrand A, Singh V, Srinivasan V, Toles R, Karikari P, Petrovics G, Seed T, Srivastava S, Papas A: Preferential radiation sensitization of prostate cancer in nude mice by nutraceutical antioxidant γ-tocotrienol. Life Sci 2006;78:2099-2104.
13. Taylor PR, Greenwald P: Nutritional interventions in cancer prevention. J Clin Oncol 2005;23:333-345.
14. Nkondjock A, Krewski D, Johnson KC, Ghadirian P: Dietary patterns and risk of pancreatic cancer. Int J Cancer 2005;114:817-823.
15. Silverman DT, Swanson CA, Gridley G, Wacholder S, Greenberg RS, Brown LM, Hayes RB, Swanson GM, Schoenberg JB, Pottern LM, Schwartz AG, Fraumeni JFJ, Hoover RN: Dietary and nutritional factors and pancreatic cancer: a case-control study based on direct interviews. J Natl Cancer Inst 1998;90:1710-1719.
16. Stolzenberg-Solomon RZ, Albanes D, Nieto FJ, Hartman TJ, Tangrea JA, Rautalahti M, Sehlub J, Virtamo J, Taylor PR: Pancreatic cancer risk and nutrition-related methyl-group availability indicators in male smokers. J Natl Cancer Inst 1999;91:535-541.
17. Husain K, Francois RA, Yamauchi T, Sebti S, Malafa MP: Delta-tocotrienol is the most bioactive natural tocotrienol in the prevention of pancreatic cancer transformation. Am Assoc Cancer Res 2008;49:3826.
18. Yap SP, Julianto T, Wong JW, Yuen KH: Simple high performance liquid chromatographic method for the determination of tocotrienols in human plasma. J Chromatogr B Biomed Sci Appl 1999;735:279-283.
19. Ng MH, Choo YM, Ma AN, Chuah CH, Hashim MA: Separation of vitamin E (tocopherol, tocotrienol and tocomonoenol) in palm oil. Lipids 2004;39:1031-1035.
20. Panfili G, Fratianni A, Irano M: Normal phase high-performance liquid chromatography method for the determination of tocopherols and tocotrienols in cereals. J Agric Food Chem 2003;51:3940-3944.
21. Cunha SC, Amaral JS, Fernandes JO, Oliveira MB: Quantification of tocopherols and tocotrienols in Portuguese olive oils using HPLC with three different detection systems. J Agric Food Chem 2006;54:3351-3356.
22. Hewavitharana AK, Lanari MC, Becu C: Simultaneous determination of vitamin E homologs in chicken meat by liquid chromatography with fluorescence detection. J Chromatogr A 2004;1025:313-317.
23. Husain K, Francois RA, Hutchinson SZ, Neuger AM, Lush R, Coppola D, Sebti S, Malafa MP: Pancreatic tissue distribution, pharmacokinetics and toxicity of bioactive δ-tocotrienol, a potential antitumor bioactive food component, in mice. FASEB J 2008;22:922.3.
24. Yap SP, Yuen KH, Wong JW: Pharmacokinetics and bioavailability of α-, γ- and δ-tocotrienols under different food status. J Pharm Pharmacol 2001;53:67-71.
25. Prottey C, Hawthorn JN: The lipids of mammalian pancreas. Biochem J 1966:101:191-196.
26. Mericle KA, Kaphalia BS, Ansari GA: Differential inhibition of hepatic, pancreatic, and plasma fatty acid ethyl ester synthase by tri -o-tolylphosphate in rats. Toxicol Appl Pharmacol 2002;179:119-125.
27. Traber MG: Vitamin E regulatory mechanisms. Annu Rev Nutr 2007;27:347-362.
28. Abe C, Uchida T, Ohta M, Ichikawa T, Yamashita K, Ikeda S: Cytochrome P450-dependent metabolism of vitamin E isoforms is a critical determinant of their tissue concentrations in rats. Lipids 2007;42:637-642.
29. Patel V, Khanna S, Roy S, Ezziddin O, Sen CK: Natural vitamin E alpha-tocotrienol: retention in vital organs in response to long-term oral supplementation and withdrawal. Free Radic Res 2006;40:763-771.
30. Ikeda S, Niwa T, Yamashita K: Selective uptake of dietary tocotrienols into rat skin. J Nutr Sci Vitaminol 2000;46:141-143.
31. Nakamura H, Furukawa F, Nishikawa A: Oral toxicity of a tocotrienol preparation in rats. Food Chem Toxicol 2001;39:799-805.
32. Hayes KC, Pronczuk A, Liang JS: Differences in the plasma transport and tissue concentrations of tocopherols and tocotrienols: observations in humans and hamsters. Proc Soc Exp Biol Med 1993;202:353-359.
33. Podda M, Weber C, Traber MC, Packer L: Simultaneous determination of tissue tocopherols, tocotrienols, ubiquinols and ubiquinones. J Lipid Res 1996;37:893-901.
34. Ikeda S, Toyoshima K, Yamashita K: Dietary sesame seeds elevate alpha and γ-tocotrienol concentrations in skin and adipose tissue of rats fed the tocotrienol-rich fraction extracted from palm oil. J Nutr 2001;131:2892-2897.
35. Kawakami Y, Tsuzuki T, Nakagawa K, Miyazawa T: Distribution of tocotrienols in rats fed a rice bran tocotrienol concentrate. Biosci Biotechnol Biochem 2007;71:464-471.
36. Tokizane T, Shiina H, Igawa M, Enokida H, Urakami S, Kawakami T, Ogishima T, Okino ST, Li LC, Tanaka Y: Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer. Clin Cancer Res 2005;11:5793-5801.
37. Lewis AM, Ough M, Hinkhouse MM, Tsao MS, Oberley LW, Cullen JJ: Targeting NAD(P)H:quinone oxidoreductase (NQO1) in pancreatic cancer. Mol Carcinog 2005;43:215-224.